APA
Riggs J. M., Hanna R. N., Rajan B., Zerrouki K., Karnell J. L., Sagar D., Vainshtein I., Farmer E., Rosenthal K., Morehouse C., de Los Reyes M., Schifferli K., Liang M., Sanjuan M. A., Sims G. P. & Kolbeck R. (2018). Characterisation of anifrolumab, a fully human anti-interferon receptor antagonist antibody for the treatment of systemic lupus erythematosus. : Lupus science & medicine.
Chicago
Riggs Jeffrey M, Hanna Richard N, Rajan Bhargavi, Zerrouki Kamelia, Karnell Jodi L, Sagar Divya, Vainshtein Inna, Farmer Erika, Rosenthal Kimberly, Morehouse Chris, de Los Reyes Melissa, Schifferli Kevin, Liang Meina, Sanjuan Miguel A, Sims Gary P and Kolbeck Roland. 2018. Characterisation of anifrolumab, a fully human anti-interferon receptor antagonist antibody for the treatment of systemic lupus erythematosus. : Lupus science & medicine.
Harvard
Riggs J. M., Hanna R. N., Rajan B., Zerrouki K., Karnell J. L., Sagar D., Vainshtein I., Farmer E., Rosenthal K., Morehouse C., de Los Reyes M., Schifferli K., Liang M., Sanjuan M. A., Sims G. P. and Kolbeck R. (2018). Characterisation of anifrolumab, a fully human anti-interferon receptor antagonist antibody for the treatment of systemic lupus erythematosus. : Lupus science & medicine.
MLA
Riggs Jeffrey M, Hanna Richard N, Rajan Bhargavi, Zerrouki Kamelia, Karnell Jodi L, Sagar Divya, Vainshtein Inna, Farmer Erika, Rosenthal Kimberly, Morehouse Chris, de Los Reyes Melissa, Schifferli Kevin, Liang Meina, Sanjuan Miguel A, Sims Gary P and Kolbeck Roland. Characterisation of anifrolumab, a fully human anti-interferon receptor antagonist antibody for the treatment of systemic lupus erythematosus. : Lupus science & medicine. 2018.